Header Logo

Connection

Philip Liebson to Follow-Up Studies

Back to Details
This is a "connection" page, showing publications Philip Liebson has written about Follow-Up Studies.
Philip Liebson
Connection Strength
0.125
Follow-Up Studies
  1. Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET): implications for reduced cardiovascular risk. Prev Cardiol. 2009; 12(1):43-50.
    View in: PubMed
    Score: 0.056
  2. ALLHAT and AFFIRM. Prev Cardiol. 2003; 6(1):54-60.
    View in: PubMed
    Score: 0.037
  3. Clinical correlates and prognostic significance of change in standardized left ventricular mass in a community-based cohort of African Americans. J Am Heart Assoc. 2015 Feb 05; 4(2).
    View in: PubMed
    Score: 0.021
  4. Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study. Hypertension. 2005 Jan; 45(1):58-63.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.